Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XV.p

Path: Exogenous lipoid pneumonia

Publications

Cherrez Ojeda I, Calderon JC, Guevara J, Cabrera D, Calero E, Cherrez A

Exogenous lipid pneumonia related to long-term use of Vicks VapoRub® by an adult patient: a case report.

BMC ear, nose, and throat disorders. 2016;16:11

Subramanian S, Kherdekar SS, Babu PG, Christianson CS

Lipoid pneumonia with Cryptococcus neoformans colonisation.

Thorax. 1982;37(4):319-20

Gattuso P, Reddy VB, Castelli MJ

Exogenous lipoid pneumonitis due to Vicks Vaporub inhalation diagnosed by fine needle aspiration cytology.

Cytopathology : official journal of the British Society for Clinical Cytology. 1991;2(6):315-6